Immunic Stock (NASDAQ:IMUX), Quotes and News Summary

Q: What sector and industry does Immunic (IMUX) operate in?

Immunic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Immunic Stock (NASDAQ: IMUX) stock price, news, charts, stock research, profile.

Open	$1.240
Close	-
Volume / Avg.	127.938K / 488.803K
Day Range	1.220 - 1.252
52 Wk Range	0.945 - 3.110
Market Cap	$109.914M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	3.22%
Days to Cover	9.45

Recent News

Immunic And 2 Other Stocks Under $2 Insiders Are Buying

The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

What's Going On With Immunic Stock?

Immunic, Inc. (NASDAQ: IMUX) shares are roughly flat following strength early Friday after the company announced a three-tranche private placement of up to $240 million.

Erica Kollmann

Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Immunic (IMUX) stock?

You can purchase shares of Immunic (NASDAQ: IMUX) through any online brokerage.

View our list of the best stock brokerages.

Who are Immunic's (IMUX) competitors?

Other companies in Immunic’s space includes: Molecular Partners (NASDAQ:MOLN), Cellectar Biosciences (NASDAQ:CLRB), Curis (NASDAQ:CRIS), FibroGen (NASDAQ:FGEN) and Armata Pharmaceuticals (AMEX:ARMP).

What is the target price for Immunic (IMUX) stock?

The latest price target for Immunic (NASDAQ: IMUX) was reported by Brookline Capital on Friday, April 5, 2024. The analyst firm set a price target for 10.00 expecting IMUX to rise to within 12 months (a possible 706.71% upside). 3 analyst firms have reported ratings in the last year.

Current Stock Price for Immunic (IMUX)?

The stock price for Immunic (NASDAQ: IMUX) is $1.2396 last updated Today at May 10, 2024 at 9:12 AM EDT.

Does Immunic (IMUX) pay a dividend?

There are no upcoming dividends for Immunic.

When is Immunic (NASDAQ:IMUX) reporting earnings?

Immunic’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Is Immunic (IMUX) going to split?

There is no upcoming split for Immunic.

What sector and industry does Immunic (IMUX) operate in?

Immunic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-